Position in PFE
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,093,424
-$1,638,956 QoQ
Shares Held
45,408
-53.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#1,279
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Trivium Point Advisory, LLC holds $28,456,605 across 8 Drug Manufacturers - General names. PFE ranks #7 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,340 | $16,000,397 | |
| 2 | JNJ |
Johnson & Johnson
|
12,027 | $3,054,497 | |
| 3 | ABBV |
AbbVie Inc.
|
10,728 | $2,699,593 | |
| 4 | MRK |
Merck & Co., Inc.
|
17,671 | $2,270,723 | |
| 5 | AMGN |
Amgen Inc
|
3,478 | $1,259,453 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
20,481 | $1,180,115 | |
| 7 | PFE |
Pfizer Inc
This page
|
45,408 | $1,093,424 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
7,111 | $898,403 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,093,424 | 45,408 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $2,732,380 | 97,307 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $2,605,237 | 104,628 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $2,656,697 | 104,266 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $896,225 | 36,973 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $794,003 | 31,334 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $935,315 | 35,255 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,093,092 | 37,771 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,128,937 | 40,348 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,009,767 | 36,388 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,143,452 | 39,717 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,364,481 | 41,136 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $1,494,086 | 40,733 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $1,699,687 | 41,659 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $2,282,844 | 44,552 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $1,903,341 | 43,495 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,227,488 | 42,485 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $2,531,915 | 48,907 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,749,013 | 46,554 | Shares | Sole | 2022-02-18 | |
| 2021-09-30 | $1,963,320 | 45,648 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,843,535 | 47,077 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,702,701 | 46,997 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,885,960 | 51,235 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,942,382 | 52,926 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $1,501,618 | 45,921 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,470,756 | 45,060 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||